What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Heart failure
- Cardiology
Piotr Ponikowski spends much of his time researching Heart failure, Internal medicine, Cardiology, Ejection fraction and Intensive care medicine.
His biological study spans a wide range of topics, including Clinical trial, Surgery, Anemia, Placebo and Heart disease.
As a member of one scientific family, Piotr Ponikowski mostly works in the field of Internal medicine, focusing on Endocrinology and, on occasion, Disease and Exercise intolerance.
Cardiology connects with themes related to Blood pressure in his study.
His Ejection fraction research is multidisciplinary, relying on both Mortality rate, Tolerability, Beta blocker, Systole and Natriuretic peptide.
His Intensive care medicine course of study focuses on MEDLINE and Position paper.
His most cited work include:
- 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (11730 citations)
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. (9345 citations)
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (6276 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Heart failure, Cardiology, Ejection fraction and In patient.
In his study, Randomized controlled trial is strongly linked to Placebo, which falls under the umbrella field of Internal medicine.
His studies deal with areas such as Renal function, Blood pressure, Intensive care medicine, Iron deficiency and Hazard ratio as well as Heart failure.
As part of his studies on Intensive care medicine, Piotr Ponikowski often connects relevant subjects like Clinical trial.
Piotr Ponikowski is studying Myocardial infarction, which is a component of Cardiology.
His study in Ejection fraction is interdisciplinary in nature, drawing from both Anesthesia, Quality of life and Dapagliflozin.
He most often published in these fields:
- Internal medicine (76.88%)
- Heart failure (76.15%)
- Cardiology (55.21%)
What were the highlights of his more recent work (between 2017-2021)?
- Heart failure (76.15%)
- Internal medicine (76.88%)
- Cardiology (55.21%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Heart failure, Internal medicine, Cardiology, Ejection fraction and In patient.
His Heart failure study combines topics from a wide range of disciplines, such as Clinical trial, Renal function, Diabetes mellitus and Hazard ratio, Confidence interval.
Piotr Ponikowski focuses mostly in the field of Hazard ratio, narrowing it down to topics relating to Adverse effect and, in certain cases, Anesthesia.
His Internal medicine research is multidisciplinary, incorporating elements of Placebo and Dapagliflozin.
The Cardiology study combines topics in areas such as Proportional hazards model and Blood pressure, Heart rate.
The concepts of his Ejection fraction study are interwoven with issues in Quality of life, Randomized controlled trial, Empagliflozin, Type 2 diabetes and Cohort.
Between 2017 and 2021, his most popular works were:
- 2018 ESC/EACTS Guidelines on myocardial revascularization. (2020 citations)
- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). (1195 citations)
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction (1150 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
